Advertisement

Ads Placeholder
Loading...

Cyclo3pss Corporation

CYPS•PNK
Healthcare
Medical - Diagnostics & Research
$0.00
$0.00(0.00%)
U.S. Market opens in 58h 2m

Cyclo3pss Corporation (CYPS) Stock Overview

Explore Cyclo3pss Corporation’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap4.1K
P/E RatioN/A
EPS (TTM)$-0.02
ROEN/A
Fundamental Analysis

AI Price Forecasts

1 Month$0.00
3 Months$0.00
1 Year Target$0.00

CYPS Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Cyclo3pss Corporation (CYPS) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 56.83, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $0.00.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of N/A and a market capitalization of 4.1K. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
0.00%
1-Month Change
0.00%
3-Month Change
900.00%
6-Month Change
400.000%
Year-to-Date (YTD) Change
900.00%
1-Year Change
400.000%
3-Year Change
400.00%
5-Year Change
-97.44%
All-Time (Max) Change
-90.91%

Contact Information

NaN
801-972-9090
7105 South Highland Drive, Salt Lake City, UT, 84121

Company Facts

40 Employees
IPO DateJul 28, 2010
CountryUS
Actively Trading

Frequently Asked Questions